A new approach to cancer treatment combines gene editing with a known chemotherapy drug, harnessing the benefits of both for better outcomes.
Theresa Noonan
Theresa is a Ph.D. candidate in computer-aided drug design at the Freie Universität Berlin and a writer for Advanced Science News.
A photoswitchable drug to better understand brain states
A drug that changes conformation in response to light allows researchers to manipulate neural activity and investigate the link between brain states and behavior.
Trojan horse inspires novel treatment for Parkinson’s disease
In this study, a drug to treat Parkinson’s disease is linked to a molecule that enables it to better penetrate the brain.
Stem cell innovators model gene and drug effects on neurodevelopment
Stem cells are used to model early nervous system development to understand how it is affected by genetic mutations and certain drugs.
Covalent inhibitors of Rho proteins suppress cancer cell invasion
A research team highlights a new strategy in anti-cancer drug development.
An antidiabetic drug in the fight against antibiotic resistance
A research team combats antibiotic-resistant superbugs by administering antibiotics together with metformin.
Zapping antibiotics back into action
A team of researchers overcomes antibiotic resistance in MRSA by combining antibiotics with irradiation.